News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Gelareh Zadeh: How Does Molecular Classification Refine Surgical and Radiotherapeutic Decision Making in Meningioma?
Photo taken from Gelareh Zadeh/X
Aug 28, 2024, 18:11

Gelareh Zadeh: How Does Molecular Classification Refine Surgical and Radiotherapeutic Decision Making in Meningioma?

Gelareh Zadeh, Dan Chair and Professor, Neurosurgery, University of Toronto shared a recent article by Justin Z. Wang on X, adding:

“With the highest accuracy the biomarkers we present in this work determine whether some one benefits from radiation therapy or not.”

Image

Molecular classification to refine surgical and radiotherapeutic decision-making in meningioma

Authors: Justin Z. Wang, Vikas Patil, Alexander P. Landry, Chloe Gui, Andrew Ajisebutu, Jeff Liu, Olli Saarela, Stephanie L. Pugh, Minhee Won, Zeel Patel, Rebeca Yakubov, Ramneet Kaloti, Christopher Wilson, Aaron Cohen-Gadol, Mohamed A. Zaazoue, Ghazaleh Tabatabai, Marcos Tatagiba, Felix Behling, Damian A. Almiron Bonnin, Eric C. Holland, Tim J. Kruser, Jill S. Barnholtz-Sloan, Andrew E. Sloan, Craig Horbinski, Silky Chotai, Lola B. Chambless, Andrew Gao, Alexander D. Rebchuk, Serge Makarenko, Stephen Yip, Felix Sahm, Sybren L. N. Maas, Derek S. Tsang, The International Consortium on Meningiomas (ICOM), C. Leland Rogers, Kenneth Aldape, Farshad Nassiri and Gelareh Zadeh.

Gelareh Zadeh: How Does Molecular Classification Refine Surgical and Radiotherapeutic Decision Making in Meningioma?

Source: Gelareh zadeh/X

Aaron Cohen-Gadol Alexander D. Rebchuk Alexander P. Landry Andrew Ajisebutu Andrew Gao C. Leland Rogers cancer Chloe Gui Christopher Wilson Craig Horbinski Derek S Tsang Felix Behling Felix Sahm Gelareh Zadeh Jeff Liu Justin Z. Wang Kenneth Aldape Minhee Won Mohamed A. Zaazoue Olli Saarela OncoDaily Oncology Ramneet Kaloti Rebeca Yakubov Serge Makarenko Stephanie L. Pugh Stephen Yip Sybren L. N. Maas The International Consortium on Meningiomas (ICOM) Vikas Patil Zeel Patel
Special Coverage
Blog
Nov 13, 2024, 09:14
Yüksel Ürün: Key takeaways on high-risk and locally advanced prostate cancer from António Rui Azevedo Freitas
Blog
Nov 13, 2024, 09:11
Clinical outcomes of early-stage triple-negative breast cancer after neoadjuvant chemotherapy
Blog
Nov 13, 2024, 09:09
Yüksel Ürün: Not all that shines is Prostate cancer – a striking reminder from Daniela Oprea-Lager
Blog
Nov 13, 2024, 09:01
Updated Results with Mitazalimab as a first-line treatment for advance pancreatic cancer
Blog
Nov 13, 2024, 08:59
Miriam Mutebi: What To Expect During A Mammogram
Insight
Nov 13, 2024, 08:56
Rachel Riechelmann: Low dose Everolimus for patients with Neuroendocrine tumors
Insight
Nov 13, 2024, 08:51
Reporting pharmacogenetic variants and cancer WGS data could guide safer prescribing
Blog
Nov 13, 2024, 08:49
Yüksel Ürün: Promising findings on SGLT2 as a biomarker for papillary RCC by Erman Akkus
Blog
Nov 13, 2024, 08:46
Karen Knudsen: Better Together - Partnering to Accelerate Progress against Cancer
Blog
Nov 13, 2024, 08:39
Eva Blondeaux on safety of pregnancy in BRCA carriers
Blog
Nov 13, 2024, 08:39
What can cancer in ferrets, opossums, and even penguins teach us about cancer in humans - AACR
Blog
Nov 13, 2024, 08:36
Research Is The Reason Nicole Seagriff had options to treat her breast cancer - The Breast Cancer Research Foundation